Global health equity is the principle that no one should be denied the chance to be healthy because of where they were born, how much money they have, or the social group they belong to. It’s both a measurable goal and a moral framework: the idea that avoidable, unjust differences in health outcomes between populations can and should be eliminated. The gap is stark. A baby born in Western Europe can expect to live to about 82, while a baby born in sub-Saharan Africa has a life expectancy of roughly 62. That 20-year difference isn’t driven by biology. It’s driven by access, resources, and power.
Equity vs. Equality in Health
These two words sound similar but describe different approaches. Health equality means giving everyone the same resources. Health equity means giving people what they specifically need to reach the same outcome. A country that builds identical hospitals in wealthy and impoverished districts has pursued equality. A country that sends more funding, staff, and mobile clinics to the district where mothers are dying at 100 times the rate of the other has pursued equity.
The distinction matters because starting points aren’t the same. Health inequities are defined as health differences that are avoidable, unnecessary, and unjust. They emerge from decades or centuries of unequal treatment, not from individual choices. Moving toward equity means selectively improving the health of disadvantaged groups, not pulling down outcomes for anyone else. At its core, health equity is social justice applied to health: the commitment that belonging to a poorer or historically marginalized group should never predict whether you live or die from a preventable cause.
What Drives the Gaps
Most of what determines a person’s health has nothing to do with hospitals or medications. The World Health Organization defines social determinants of health as the conditions in which people are born, grow, live, work, and age, along with their access to power, money, and resources. People with limited access to quality housing, education, social protections, and job opportunities face higher rates of illness and death. These aren’t background factors. They are the primary drivers of health inequity worldwide.
The WHO’s Commission on Social Determinants of Health identified three areas that matter most: improving daily living conditions, tackling the unequal distribution of power and money that shapes those conditions, and measuring the problem so progress can be tracked. Policies around urbanization, trade, labor, and governance all feed into whether a community has clean water, safe food, functioning schools, and nearby healthcare. When those systems fail, health outcomes collapse, and the burden falls hardest on the poorest populations.
Where the Disparities Are Most Visible
Maternal mortality is one of the clearest markers of global health inequity. High-income countries have reduced maternal deaths to around 10 per 100,000 live births. Some low-income countries have maternal mortality ratios more than 100 times that figure, with women dying from conditions like pre-eclampsia that are routinely managed in wealthier settings. The United Nations’ Sustainable Development Goals set a target of reducing the global ratio to below 70 per 100,000 by 2030, a goal that remains far out of reach for many nations.
Life expectancy gaps tell a similar story. The 20-year divide between Western Europe and sub-Saharan Africa reflects compounding disadvantages: fewer healthcare workers, less infrastructure, higher rates of infectious disease, weaker food systems, and political instability. These are not inevitable conditions. They’re the predictable result of how resources have been distributed globally for generations.
The Healthcare Workforce Shortage
You can’t have health equity without people to deliver care, and the world doesn’t have enough of them. A 2016 global strategy projected a shortage of 18 million health workers by 2030. More recent estimates have revised that number to about 10 million, a meaningful improvement but still an enormous gap. If every country aimed to reach a strong level of universal health coverage by 2030, the shortage could be as high as 78 million workers.
The shortages are not evenly spread. Wealthier countries recruit trained doctors and nurses from lower-income nations, leaving the places with the greatest need even further behind. Community health workers have proven to be a powerful, cost-effective response. Programs that train local, trusted members of a community to deliver basic care, manage chronic diseases like diabetes, connect patients to hospitals, and promote cancer screenings have improved outcomes across multiple settings. These workers bridge the gap between formal healthcare systems and the people those systems fail to reach, often at lower cost because they reduce emergency visits and hospitalizations.
How Drug Patents Shape Access
Intellectual property laws play a direct role in who gets lifesaving medicine and who doesn’t. Patents give pharmaceutical companies the temporary right to be the sole manufacturer of a drug or vaccine, which limits supply and raises prices. During the COVID-19 pandemic, this tension became impossible to ignore. Dozens of countries and civil society organizations argued that patent protections were actively blocking the mass production of vaccines, therapeutics, and medical devices needed to end the crisis.
The pricing disparities were concrete. South Africa reported paying $5.25 per dose for AstraZeneca’s vaccine while European Union members paid $3.50. Voluntary licensing agreements, where a patent holder allows others to manufacture a product, were criticized for lacking transparency and imposing geographic restrictions that prevented export to developing countries. The existing legal mechanism that allows countries to override patents in emergencies, known as compulsory licensing, has been successfully used only once in its history, to import pharmaceuticals to Rwanda. Low- and middle-income countries have historically been pressured by trade partners and pharmaceutical corporations not to use it.
The Digital Health Divide
Telehealth, health apps, and AI-powered diagnostics are expanding rapidly, but not for everyone. The “digital health divide” mirrors other inequities: the communities most likely to benefit from remote care are often the least likely to have the internet access, devices, or digital literacy needed to use it. Being able to navigate health technology is now its own determinant of health, creating a second layer of disadvantage on top of existing barriers.
Trust is another obstacle. Older adults, people from minoritized ethnic backgrounds, and those with less formal education are less likely to engage with digital health tools, especially when it’s unclear how their data is being used or whether the information is credible. Closing this gap requires technology designers to be transparent about data practices, AI use, and information sourcing. Without deliberate effort, digital health risks widening the very inequities it could help reduce.
What Progress Looks Like
Global health equity isn’t a single policy or program. It’s a reorientation of priorities. Progress means directing resources where the need is greatest rather than where the return on investment is highest. It means training and retaining healthcare workers in the communities that need them, reforming trade rules that keep medicines unaffordable, investing in housing and education as health interventions, and designing technology that works for the people currently left out.
The gaps are enormous, but they are not mysterious. The 20-year life expectancy divide, the 100-fold difference in maternal deaths, the millions of missing healthcare workers: these are all traceable to specific, changeable conditions. Health equity treats those conditions as the problem, not the people living in them.